3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
2
Terminated
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
11
Carcinoma, Non-Small-Cell Lung
11
Carcinoma, Transitional Cell
9
Carcinoma, Renal Cell
8
Colorectal Neoplasms
7
Urinary Bladder Neoplasms
6
Ovarian Neoplasms
6
Neoplasm Metastasis
6
Squamous Cell Carcinoma of Head and Neck
4
Recurrence
3
Glioblastoma
3
Carcinoma, Neuroendocrine
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Sarcoma
2
Neuroendocrine Tumors
2
Kidney Neoplasms
2
Kidney Diseases
2
Head and Neck Neoplasms
2
Glioma
2
Fallopian Tube Neoplasms
2
Carcinoma, Merkel Cell
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Urologic Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Testicular Neoplasms
1
Testicular Diseases
1
Interventions
Docetaxel
158
Prednisone
131
Leuprolide
95
bicalutamide
86
enzalutamide
83
Radiotherapy
80
Goserelin
80
Abiraterone Acetate
76
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
54
Magnetic Resonance Spectroscopy
46
Zoledronic Acid
44
gallium 68 PSMA-11
37
Flutamide
34
abiraterone
32
Estramustine
32
radium Ra 223 dichloride
30
apalutamide
27
Surveys and Questionnaires
26
Gonadotropin-Releasing Hormone
26
Androgen Antagonists
25
cabazitaxel
24
Radiosurgery
24
Dutasteride
22
sipuleucel-T
21
Prednisolone
21
Triptorelin Pamoate
20
Paclitaxel
20
luprolide acetate gel depot
19
Radiation
19
Exercise
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Prostatic Neoplasms
×
avelumab
×
Clear all
NCT03179410
2021-03-05
PICK-NEPC
Duke University
Phase 2
Completed
15 enrolled
12 charts